Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68001-686

This is a description for Metoprolol Succinate Extended-Release Tablets, USP. Each tablet contains 95 mg metoprolol succinate equivalent to 100 mg metoprolol tartrate. The usual dosage should be followed as indicated in the package insert. It is essential to keep this medication out of the reach of children. The tablets should be stored within a temperature range of 20°C to 30°C. This package is child-resistant and manufactured by Yichang Humanwell Oral Solid Dosage Plant in China for BluePoint Laboratories, a product of Spain. The revision date for this product is September 2025.*

This is a description of Metoprolol Succinate Extended-Release Tablets, USP. Each tablet contains 95 mg of metoprolol succinate equivalent to 100 mg of metoprolol tartrate, USP. The usual dosage information can be found in the package insert. It is important to keep this medication out of the reach of children. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). Dispense in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by BluePoint Laboratories in Spain. Rev. 09/2025.*

Each extended-release tablet contains 190 mg metoprolol succinate equivalent to 200 mg metoprolol tartrate, USP. The usual dosage information can be found in the package insert. This medication should be kept out of reach of children. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) according to USP Controlled standards. The packaging is child-resistant and contains 100 tablets. The tablets are manufactured by Yichang Humanwell Oral Solid Dosage Plant in Yichang, Hubei, China, for BluePoint Laboratories, a product of Spain. This batch is set to expire in September 2025.*

This is a description of a medication called Metoprolol Succinate extended-release tablet. It contains 23.75 mg of metoprolol succinate and is equivalent to 25 mg metoprolol tartrate. The warning is to keep the medication out of the reach of children. The usual dosage information is available in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) under controlled room temperature. The packaging is child-resistant. The medication is manufactured by Yichang Humanwell Oral Solid Dosage Plant in China for BluePoint Laboratories, a product of Spain. The package contains 100 tablets with the expiration date/revision being 09/2025.*

This is a description of Metoprolol Succinate Extended-Release Tablets, which are prescribed medication with 500 tablets in the package. Each tablet contains 23.75 mg of metoprolol succinate equivalent to 25 mg of metoprolol tartrate. The recommended dosage is stated in the package insert. It is crucial to keep this medication out of reach of children. Store between 20° to 25°C with permissible excursions to 15° to 30°C. The packaging is child-resistant, and it is manufactured by Yichang Humanwell Oral Solid Dosage Plant in Hubei, China, for BluePoint Laboratories. The product is of Spanish origin with a revision date of 09/2025.*

This text contains information about a medication called Metoprolol Succinate extended-release tablets, with a dosage of 47.5 mg. It indicates that the tablets are equivalent to 50 mg of Metoprolol Tartrate USP and provides guidance for storage conditions and child safety precautions. It also mentions the manufacturer as Yichang Humanwell Oral Solid Dosage Plant in China for BluePoint Laboratories. It is recommended to refer to the package insert for usual dosage information.*

This text provides information on a medication containing 47.5 mg of metoprolol succinate in extended-release tablets. The tablets are equivalent to 50 mg of metoprolol tartrate, USP. The usual dosage instructions are mentioned in the package insert. The medication is warned to be kept out of reach of children and stored at a temperature between 20°C to 25°C. Excursions to 15°C to 30°C are permitted. The packaging is child-resistant. The tablets are manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by BluePoint Laboratories. It contains 500 tablets with an expiration date of September 2025.*

This is a table showing results for Subgroups in the MERIT-HF study, including total mortality, total hospitalization for heart failure, and other outcomes based on different criteria such as NYHA classification, ejection fraction, etiology, sex, race, previous myocardial infarction, diabetes mellitus, blood pressure, and heart rate. The table also includes relative risk and 95% confidence interval for the subgroups. The study was conducted in the United States and involved participants categorized by New York Heart Association (NYHA) classification, ejection fraction (EF), history of myocardial infarction (MI), and heart rate.*